HOSPITAL UNIVERSITARIO QUIRÓNSALUD MADRID
Departamento
Universitat Autònoma de Barcelona
Barcelona, EspañaPublicaciones en colaboración con investigadores/as de Universitat Autònoma de Barcelona (31)
2024
-
Developmental outcome of electroencephalographic findings in SYNGAP1 encephalopathy
Frontiers in Cell and Developmental Biology, Vol. 12
2022
-
Awareness of Diagnosis in Persons with Early-Stage Alzheimer’s Disease: An Observational Study in Spain
Neurology and Therapy, Vol. 11, Núm. 3, pp. 1183-1192
-
Delphi Consensus on Therapeutic Strategies and Health Prevention of hypovitaminosis D
Revista de Osteoporosis y Metabolismo Mineral, Vol. 14, Núm. 4, pp. 115-124
-
Preclinical and randomized phase I studies of plitidepsin in adults hospitalized with COVID-19
Life science alliance, Vol. 5, Núm. 4
-
Structural Remodeling and Rotational Activity in Persistent/Long-Lasting Atrial Fibrillation: Gender-Effect Differences and Impact on Post-ablation Outcome
Frontiers in Cardiovascular Medicine, Vol. 9
2021
-
Environmental exposure during pregnancy: Influence on prenatal development and early life: A comprehensive review
Fetal Diagnosis and Therapy, Vol. 48, Núm. 4, pp. 245-257
2020
-
Incidence and costs of cardiovascular events in Spanish patients with type 2 diabetes mellitus: A comparison with general population, 2015
BMJ Open Diabetes Research and Care, Vol. 8, Núm. 1
-
Interatrial block can occur in the absence of left atrial enlargement: New experimental model
PACE - Pacing and Clinical Electrophysiology, Vol. 43, Núm. 4, pp. 427-429
-
The evolving microbiome from pregnancy to early infancy: A comprehensive review
Nutrients, Vol. 12, Núm. 1
2019
-
Contribution of altered endocannabinoid system to overactive mTORC1 signaling in focal cortical dysplasia
Frontiers in Pharmacology, Vol. 9, Núm. JAN
-
Multiparametric magnetic resonance imaging-guided salvage radiotherapy in prostate cancer
Reports of Practical Oncology and Radiotherapy, Vol. 24, Núm. 5, pp. 472-480
-
Systemic manifestations of primary Sjögren's syndrome out of the ESSDAI classification: Prevalence and clinical relevance in a large international, multi-ethnic cohort of patients
Clinical and Experimental Rheumatology, Vol. 37, pp. S97-S106
-
The Big Data Sjögren consortium: A project for a new data science era
Clinical and Experimental Rheumatology, Vol. 37, pp. S19-S23
2018
-
Health care and societal costs of the management of children and adolescents with attention-deficit/hyperactivity disorder in Spain: A descriptive analysis
BMC Psychiatry, Vol. 18, Núm. 1
-
How immunological profile drives clinical phenotype of primary Sjögren's syndrome at diagnosis: Analysis of 10,500 patients (Sjögren Big Data Project)
Clinical and Experimental Rheumatology, Vol. 36, pp. S102-S111
-
Importance of 68Ga-PSMA PET/CT in hospital practice. View of the radiation oncologist
Revista Espanola de Medicina Nuclear e Imagen Molecular, Vol. 37, Núm. 5, pp. 302-314
-
Low cytomegalovirus seroprevalence in early multiple sclerosis: a case for the ‘hygiene hypothesis’?
European Journal of Neurology, Vol. 25, Núm. 7, pp. 925-933
-
Severe, life-threatening phenotype of primary Sjögren's syndrome: Clinical characterisation and outcomes in 1580 patients (the GEAS-SS Registry)
Clinical and Experimental Rheumatology, Vol. 36, pp. S121-S129
2017
-
Characterization and risk estimate of cancer in patients with primary Sjögren syndrome
Journal of Hematology and Oncology, Vol. 10, Núm. 1
-
Romosozumab (sclerostin monoclonal antibody) versus teriparatide in postmenopausal women with osteoporosis transitioning from oral bisphosphonate therapy: a randomised, open-label, phase 3 trial
The Lancet, Vol. 390, Núm. 10102, pp. 1585-1594